COVID-19 Vaccines Show the Patent System Works

Geoffrey A. Manne & Kristian Stout January 4, 2021

Truth on The Market View Original Source

• 
  Back
  to Top

With the COVID-19 vaccine made by Moderna joining the one from Pfizer and BioNTech in gaining approval from the U.S. Food and Drug Administration, it should be time to celebrate the U.S. system of pharmaceutical development. The system’s incentives—notably granting patent rights to firms that invest in new and novel discoveries—have worked to an astonishing degree, producing not just one but as many as three or four effective approaches to end a viral pandemic that, just a year ago, was completely unknown.

Read the full piece here.